| Further improvement in IVF outcome may need more than consistency in ovarian stimulation. | |
| | |
MedLine Citation:
|
PMID: 16895624 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
It is agreed that reliability of hormonal products, starting with recombinant technology, has improved uniformity of ovarian response to a specified dosage, and that this has resulted in better pregnancy rates. Nevertheless, IVF cycle cancellation rate has not experienced a substantial decline in the last 5-10 years. We feel that further improvement will be more likely to be achieved once we gain better understanding of factors intrinsic to oocyte biology, such as oocyte ageing and oocyte depletion. |
| | |
Authors:
|
Jose P Balmaceda; Juan-Enrique Schwarze |
Related Documents
:
|
4040574 - Follicular development, ovulation, fertilization and fetal development in tenrecs (tenr... 10319314 - Severe hemolytic disease from rhesus anti-c antibodies in a surrogate pregnancy after o... 18239354 - Piezo-assisted in vitro fertilization of mouse oocytes with spermatozoa retrieved from ... 19720394 - Ovarian superstimulation, transrectal ultrasound-guided oocyte recovery, and ivf in rhi... 3394754 - Diabetic nephropathy: pregnancy performance and fetomaternal outcome. 426024 - Effects of maternal smoking on circulating catecholamine levels and fetal heart rates. |
Publication Detail:
|
Type: Comment; Journal Article |
Journal Detail:
|
Title: Reproductive biomedicine online Volume: 13 ISSN: 1472-6483 ISO Abbreviation: Reprod. Biomed. Online Publication Date: 2006 Aug |
Date Detail:
|
Created Date: 2006-08-09 Completed Date: 2006-12-07 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101122473 Medline TA: Reprod Biomed Online Country: England |
Other Details:
|
Languages: eng Pagination: 156-7 Citation Subset: IM |
Affiliation:
|
Reproductive Medicine Unit, Clinica Las Condes, Lo Fontecilla 441, Santiago, Chile. jbalmace@clinicalascondes.cl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Female Fertilization in Vitro / standards* Follicle Stimulating Hormone / therapeutic use* Follicle Stimulating Hormone, Human / therapeutic use Glycoprotein Hormones, alpha Subunit / therapeutic use Humans Infertility, Female / drug therapy Ovulation Induction / standards* Pregnancy Pregnancy Rate |
| Chemical | |
Reg. No./Substance:
|
0/Follicle Stimulating Hormone, Human; 0/Glycoprotein Hormones, alpha Subunit; 9002-68-0/Follicle Stimulating Hormone |
| Comments/Corrections | |
Comment On:
|
Reprod Biomed Online. 2006 Jun;12(6):663-8
[PMID:
16792840
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Evidence-based follitropin.
Next Document: IVM--the first choice for IVF in Italy.